MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Alprazolam reduces freezing of gait and improves freezing-related gait measures

    A. Al Jaja, T. Sue, K. Seergobin, J. Grahn, P. Macdonald (London, Canada)

    Objective: We investigated the effect of acutely reducing anxiety with the benzodiazepine, Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD). Background:…
  • 2022 International Congress

    Relationship between gait speed and functional measurements in Parkinson’s disease

    D. Iucksch, B. Yamaguchi, L. Araujo, V. Israel (CURITIBA, Brazil)

    Objective: The present study aims to relate gait speed in Parkinson's disease (PD) with functional measures of muscle strength, balance and physical capacity. Background: PD…
  • 2022 International Congress

    Rapid onset of good ON time and improvement in motor-state stability in aPD patients after treatment with continuous subcutaneous foslevodopa/foscarbidopa

    R. Pahwa, M. Soileau, D. Standaert, V. Fung, T. Kimber, I. Malaty, A. Merola, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, N. Fisseha, A. Jeong, M. Facheris, P. Kukreja, J. Zamudio, J. Aldred (Kansas City, USA)

    Objective: To evaluate time to ON without troublesome dyskinesia (‘good ON’) and patterns of motor-state stability throughout the day in patients with advanced Parkinson’s disease…
  • 2022 International Congress

    Deep Brain Stimulation in Parkinson’s disease: Challenges of a young experience in southern Morocco

    Y. Naji, K. Saghir, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: The objective of our research was to describe the epidemiological, therapeutic features and effectiveness of deep brain stimulation in operated patients. To cite the…
  • 2022 International Congress

    MoCA and MMSE subitems’ sensitivity across the PD-cognitive spectrum

    E. Fiorenzato, L. Zurlo, C. Cianci, M. Garon, T. Gandolfi, F. Pistonesi, L. Weis, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To determine which Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) subitems are more sensitive in detecting cognitive abnormalities in patients with PD…
  • 2022 International Congress

    Polypharmacy and drug-related problems in geriatric patients with Parkinson’s Disease

    PV. Menon, CY. Lee, CH. Tan, S. Kumar Seetharaman (Singapore, Singapore)

    Objective: To identify and address polypharmacy and drug related problems (DRPs) in geriatric patients (>65 years old) in an Integrated Parkinson’s Disease clinic. Background: Management…
  • 2022 International Congress

    Climb up! Head up! Climbing improves posture in Parkinson’s disease. A randomised controlled trial.

    A. Langer, D. Roth, A. Santer, A. Flotz, J. Gruber, L. Wizany, S. Hasenauer, R. Pokan, P. Dabnichki, M. Treven, S. Zimmel, M. Schmoeger, U. Willinger, L. Gassner, W. Maetzler, H. Zach (Vienna, Austria)

    Objective: We investigated the role of sport climbing in correcting stooped posture in Parkinson Disease patients. Background: Parkinson’s Disease (PD) is a neurodegenerative movement disorder…
  • 2022 International Congress

    Data-driven identification of distinct fronto-subcortical and cortical-posterior subtypes of cognitive decline in Parkinson’s disease

    M. Grothe, M. Labrador-Espinosa, S. Jesús, F. Roldán Lora, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, SG. Coppadis, P. Martínez-Martín, J. Kulisevsky, D. Santos-García, P. Mir (Seville, Spain)

    Objective: To use a novel data-driven approach, Subtype and Stage inference (SuStain)[1], for identifying distinct subtypes of domain-specific cognitive decline in Parkinson’s disease (PD), and…
  • 2022 International Congress

    Cortico-cortical connectivity is normalised by levodopa in tremor-dominant Parkinson’s disease

    BK. Rurak, JP. Rodrigues, BD. Power, PD. Drummond, AM. Vallence (Murdoch, Australia)

    Objective: The aim of this study was to examine whether connectivity between the supplementary motor area and primary motor cortex (SMA-M1) is implicated in Parkinson’s…
  • 2022 International Congress

    Intraoperative quantification of MDS-UPDRS tremor measurements using 3D accelerometry

    A. Smid, J. Elting, J. van Dijk, E. Otten, D. Oterdoom, K. Tamasi, T. Heida, T. van Laar, G. Drost (Groningen, Netherlands)

    Objective: This study focuses on translating parkinsonian tremor tests to an objective method to rate tremor severity using 3D accelerometry, that can be used during…
  • « Previous Page
  • 1
  • …
  • 336
  • 337
  • 338
  • 339
  • 340
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley